Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
18.46
+1.68 (10.01%)
Jun 20, 2025, 2:45 PM CST
SHA:603538 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 73.99 | 66.81 | 11.59 | 338.86 | 142.53 | 155.96 | Upgrade
|
Depreciation & Amortization | 133.03 | 133.03 | 118.48 | 101.76 | 98.94 | 87.54 | Upgrade
|
Other Amortization | 4.59 | 4.59 | 7.66 | 7.5 | 4.82 | 3.07 | Upgrade
|
Loss (Gain) From Sale of Assets | 1.08 | 1.08 | -17.51 | 20.31 | 6.17 | 2.14 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | - | -56.87 | Upgrade
|
Loss (Gain) From Sale of Investments | -4.84 | -4.84 | 0.57 | -183.39 | -21.11 | -21.83 | Upgrade
|
Provision & Write-off of Bad Debts | 0.76 | 0.76 | 6.12 | -0.7 | 2.66 | -0.83 | Upgrade
|
Other Operating Activities | 93.19 | 71.42 | 66.39 | 53.08 | 36.03 | 61.35 | Upgrade
|
Change in Accounts Receivable | -91.69 | -91.69 | -98.84 | -213.63 | -50.86 | -28.23 | Upgrade
|
Change in Inventory | -185.43 | -185.43 | -49.56 | -182.99 | -124.68 | -82.3 | Upgrade
|
Change in Accounts Payable | 67.15 | 67.15 | -51.17 | 351.4 | 134.36 | 63.34 | Upgrade
|
Change in Other Net Operating Assets | 24.9 | 24.9 | 24.33 | 24.96 | 12.77 | 26.36 | Upgrade
|
Operating Cash Flow | 126.48 | 97.54 | 9.13 | 276.95 | 220.63 | 228.06 | Upgrade
|
Operating Cash Flow Growth | - | 967.95% | -96.70% | 25.53% | -3.26% | 26.87% | Upgrade
|
Capital Expenditures | -142.63 | -179.4 | -219.54 | -571.62 | -529.89 | -316.21 | Upgrade
|
Sale of Property, Plant & Equipment | 2.21 | 2.17 | 0.18 | 3.38 | 2.13 | 0.48 | Upgrade
|
Cash Acquisitions | - | - | - | - | -47.1 | - | Upgrade
|
Divestitures | - | - | 109.96 | 487.93 | - | - | Upgrade
|
Investment in Securities | 100.86 | 72.99 | -222.74 | 181.48 | -90.25 | -182.97 | Upgrade
|
Other Investing Activities | 29.75 | 4.46 | 8.54 | -50.92 | 61.86 | 15.26 | Upgrade
|
Investing Cash Flow | -9.81 | -99.79 | -323.61 | 50.26 | -603.25 | -483.44 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | - | 32.23 | Upgrade
|
Long-Term Debt Issued | - | 717.52 | 708.32 | 769.02 | 847.8 | 1,006 | Upgrade
|
Total Debt Issued | 816.34 | 717.52 | 708.32 | 769.02 | 847.8 | 1,039 | Upgrade
|
Long-Term Debt Repaid | - | -709.54 | -620.47 | -753.93 | -793.74 | -812.66 | Upgrade
|
Total Debt Repaid | -809.38 | -709.54 | -620.47 | -753.93 | -793.74 | -812.66 | Upgrade
|
Net Debt Issued (Repaid) | 6.96 | 7.98 | 87.85 | 15.08 | 54.07 | 225.92 | Upgrade
|
Issuance of Common Stock | 35.58 | 35.58 | 2.75 | 4.46 | 27.87 | - | Upgrade
|
Repurchase of Common Stock | -0.63 | -0.63 | -1.12 | -0.1 | -0.17 | -0.53 | Upgrade
|
Common Dividends Paid | -24.23 | -22.71 | -59.24 | -50.03 | -13.83 | -41.5 | Upgrade
|
Other Financing Activities | 11.31 | 12.16 | 24.63 | -147.87 | 515.22 | -17.39 | Upgrade
|
Financing Cash Flow | 28.99 | 32.39 | 54.87 | -178.46 | 583.15 | 166.5 | Upgrade
|
Foreign Exchange Rate Adjustments | 3.78 | 8.84 | -3.45 | 14.63 | -2.29 | -2.04 | Upgrade
|
Net Cash Flow | 149.44 | 38.98 | -263.06 | 163.39 | 198.23 | -90.92 | Upgrade
|
Free Cash Flow | -16.15 | -81.87 | -210.41 | -294.67 | -309.26 | -88.16 | Upgrade
|
Free Cash Flow Margin | -1.17% | -5.96% | -17.30% | -20.22% | -24.58% | -7.39% | Upgrade
|
Free Cash Flow Per Share | -0.07 | -0.38 | -0.91 | -1.30 | -1.45 | -0.43 | Upgrade
|
Cash Income Tax Paid | - | -8.63 | 55 | 35.09 | -48.68 | -24.6 | Upgrade
|
Levered Free Cash Flow | -93.49 | -124.44 | -254.43 | -78.85 | -296.94 | -176.41 | Upgrade
|
Unlevered Free Cash Flow | -61.35 | -94.27 | -236.27 | -61.69 | -280.02 | -161.54 | Upgrade
|
Change in Net Working Capital | 129.21 | 123.96 | 179.38 | -247.6 | -34.63 | 42.29 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.